Safety of polyethylene glycol 3350 for the treatment of chronic constipation in children.

@article{Pashankar2003SafetyOP,
  title={Safety of polyethylene glycol 3350 for the treatment of chronic constipation in children.},
  author={Dinesh S. Pashankar and Vera Loening-Baucke and Warren P. Bishop},
  journal={Archives of pediatrics & adolescent medicine},
  year={2003},
  volume={157 7},
  pages={661-4}
}
OBJECTIVES To assess the clinical and biochemical safety profile of long-term polyethylene glycol 3350 (PEG) therapy in children with chronic constipation and to assess pediatric patient acceptance of PEG therapy. DESIGN Prospective observational study. SETTING Pediatric clinics at a referral center. Patients Eighty-three children (44 with chronic constipation, 39 with constipation and encopresis) receiving PEG therapy for more than 3 months. MAIN OUTCOME MEASURES Clinical adverse effects… CONTINUE READING